Moderna Inc MRNA:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD

After Hours: Last | 7:05 PM EDT

124.89

-0.26 (-0.21%)

Volume

57,213

125.15

-0.47 (-0.37%)

Volume

2,296,572

52 week range

115.03 - 376.65

Open124.78
Day High127.64
Day Low122.93
Prev Close125.62
52 Week High376.65
52 Week High Date11/29/21
52 Week Low115.03
52 Week Low Date09/29/22

Key Stats

Market Cap48.959B
Shares Out391.20M
10 Day Average Volume3.74M
Dividend-
Dividend Yield-
Beta1.66
YTD % Change-50.72

KEY STATS

Open124.78
Day High127.64
Day Low122.93
Prev Close125.62
52 Week High376.65
52 Week High Date11/29/21
52 Week Low115.03
52 Week Low Date09/29/22
Market Cap48.959B
Shares Out391.20M
10 Day Average Volume3.74M
Dividend-
Dividend Yield-
Beta1.66
YTD % Change-50.72

RATIOS/PROFITABILITY

EPS (TTM)32.80
P/E (TTM)3.82
Fwd P/E (NTM)8.09
EBITDA (TTM)15.945B
ROE (TTM)113.86%
Revenue (TTM)22.995B
Gross Margin (TTM)82.29%
Net Margin (TTM)61.12%
Debt To Equity (MRQ)4.24%

EVENTS

Earnings Date11/02/2022(est)
Ex Div Date-
Div Amount-
Split Date-
Split Factor-

Latest On Moderna Inc

Goldman analysts predict these stocks have the most to gainOctober 4, 2022CNBC.com
What Cramer is watching — back to 2020 on S&P 500, possible major OPEC+ oil cutOctober 3, 2022CNBC.com
How to perfectly time your new omicron-specific Covid boosterOctober 1, 2022CNBC.com
Pro Picks: Watch all of Friday's big stock calls on CNBCSeptember 30, 2022CNBC.com
Covid vaccination linked to small increase in menstrual cycle length: NIH studySeptember 28, 2022CNBC.com

Content From Our Affiliates

What You Missed On Wall Street On MondayOctober 3, 2022TipRanks
What You Missed On Wall Street This MorningOctober 3, 2022TipRanks
Moderna Refuses to Sell its Vaccine Tech to ChinaOctober 3, 2022TipRanks
Fly Intel: Top five weekend stock storiesOctober 2, 2022TipRanks
Moderna refuses China request to reveal vaccine technology, FT reportsOctober 2, 2022TipRanks

Profile

Moderna, Inc. is a biotechnology company that is focused on creating a transformative medicines based on messenger ribonucleic acid (mRNA), to improve the lives of patients. The Company’s mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane, or secreted proteins that have a therapeutic or preventive benefit with the potential to address a range of spectrum of diseases. It is developing vaccines and therapeutics for infectious diseases...

Noubar Afeyan Ph.D.

Non-Executive Independent Chairman of the Board, Co-Founder

Stephane Bancel

Chief Executive Officer, Director

Stephen Hoge M.D.

President

James Mock

Chief Financial Officer

Address

200 Technology Sq

Cambridge, MA

02139-3578

United States

https://www.modernatx.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
BNTX BioNTech SE	137.53	+0.34	+0.25%
BIIB Biogen Inc	262.26	+0.57	+0.22%
REGN Regeneron Pharmaceuticals Inc	731.86	-13.82	-1.85%
ILMN Illumina Inc	212.72	-5.80	-2.65%
ALNY Alnylam Pharmaceuticals Inc	202.37	+1.35	+0.67%